Company profile
Contact details
Kanglaite Pharmaceutical Co., Ltd. is a high-tech enterprise located in Hangzhou, China with its production line introduced from Europe while GMP standard is strictly followed.
The company manufactures world-wide patented botanical anticancer drug Kanglaite Injection (KLT) that is a novel dual-function and molecular targeting emulsion with active substance extracted from a herb 'semen coicis'. KLT has notable function in killing cancer cells while enhancing body immune function. It is able to control cancerous pain, resist cachexia, prevent metastasis and improve patient KPS, QOL, MST so as to extend survival. 750,000 cases have applied KLT since its launch in China in 1995.
In 2001 FDA approved KLT to start clinical study in USA and the Russian Ministry of Health issued KLT registr ...ation certificate in December 2003. Studies at Johns Hopkins university USA confirmed again its anticancer machanism. Currently KLT Phase II study in carried out in USA and this product is being registered in GCC, KSA, UAE, Yemen, Syria and Brazil.
We seek overseas agent company to register, import and distribute KLT so that it brings benefit to more cancer patients in the world.
Contact us if your company is oncologically professional and feels intrested in the cooperation. Read more
The company manufactures world-wide patented botanical anticancer drug Kanglaite Injection (KLT) that is a novel dual-function and molecular targeting emulsion with active substance extracted from a herb 'semen coicis'. KLT has notable function in killing cancer cells while enhancing body immune function. It is able to control cancerous pain, resist cachexia, prevent metastasis and improve patient KPS, QOL, MST so as to extend survival. 750,000 cases have applied KLT since its launch in China in 1995.
In 2001 FDA approved KLT to start clinical study in USA and the Russian Ministry of Health issued KLT registr ...ation certificate in December 2003. Studies at Johns Hopkins university USA confirmed again its anticancer machanism. Currently KLT Phase II study in carried out in USA and this product is being registered in GCC, KSA, UAE, Yemen, Syria and Brazil.
We seek overseas agent company to register, import and distribute KLT so that it brings benefit to more cancer patients in the world.
Contact us if your company is oncologically professional and feels intrested in the cooperation. Read more
Type of Dosage Forms
- Medicated Infusions
Supplier Category
- Exporter of GMP Dosage Forms
- Manufacturer of GMP Dosage Forms
Other Products
- Packagings